WYNN RESORTS LTD DL-,01 Aktie (ISIN US / WKN ). Aktueller Kurs, historische Charts, Analystenchecks und aktuelle Nachrichten zur. Aktie Wynn Resorts Ltd. WKN ISIN US Direkt zum Inhalt. Wynn Resorts ist ein börsennotierter US-amerikanischer Konzern der Hotel- und Unterhaltungsindustrie. Das Unternehmen betreibt mehrere Hotels mit angeschlossenen Spielkasinos. Das bekannteste ist das Wynn Las Vegas, welches Gründer Steve Wynn ab.
WYNN RESORTS LTD DL-,01 AktieDie letzten Wynn Resorts, Limited (WYNN) Aktienkurse, Verläufe, Nachrichten und weitere wichtige Informationen für den Aktienhandel und Investitionen finden. News zur WYNN RESORTS AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ Las Vegas Sands, Wynn Are Macau Names to Remember Following Forgettable. Aktuelle Börsenkurse, den Aktien-Chart, Kursinformationen und die Kursentwicklung bzw. News zur Aktie Wynn Resorts Limited (WKN , ISIN.
Wynn Resorts Limited Recent News VideoWynn Stock Analysis - Gambling on 2x+! $WYNN Resorts FTW?
Offers may be subject to change without notice. Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Wynn Resorts Says On Nov. Wynn Resorts, Limited Reports Third Quarter Results. Gan Ltd -. Wynn Resorts, Limited Wynn Resorts is a developer, owner and operator of destination casino resorts that integrate accommodations and a range of amenities, including dining outlets, retail offerings, entertainment theaters and meeting complexes.
The Company's segments include Macau Operations and Las Vegas Operations. The Company's Macau Operations include Wynn Macau and Wynn Palace.
It also includes Encore, an expansion at Wynn Macau. The Company's Las Vegas Operations include Wynn Las Vegas and Encore, an expansion at Wynn Las Vegas.
Wynn Las Vegas is located at the intersection of the Las Vegas Strip and Sands Avenue. As of December 31, , it occupied approximately acres of land fronting the Las Vegas Strip.
As of December 31, , the Company owned approximately 18 acres across Sands Avenue. The Company is constructing Wynn Boston Harbor, an integrated casino resort in Everett, Massachusetts.
Contact Info. LAS VEGAS, NV. United States. Executive Leadership. Traded as. China Las Vegas Valley Massachusetts.
Operating income. Net income. Securities and Exchange Commission. February 28, Retrieved May 26, Retrieved 3 March The New York Times.
Retrieved 2 March Las Vegas Review-Journal. Retrieved 16 January Wynn , p. Zacks Investment Research. A new year, a new addition to the stock portfolio — what can make more sense than that?
The right time to buy, of course, is when stocks are priced at the bottom. But the markets are up. With a market environment like that, finding stocks that are caught in the doldrums is harder than it looks.
That's where the Wall Street pros can lend a hand. Not to mention each has earned a Moderate or Strong Buy consensus rating.
Esperion ESPR We will start with Esperion, a company that specializes in therapies for the treatment of elevated low-density lipoprotein cholesterol levels — a major factor contributing to heart disease.
In February , both Nexletol and Nexlizet were approved as oral treatments to lower LDL-C. Bempedoic acid remains in clinical trials of its efficacy in risk reduction for cardiovascular disease.
The trial, called CLEAR Outcomes, is a large-scale, long-term study, tracking more than 14, patients with top-line data expected in the second half of The study covers 1, locations in 32 countries around the world.
Esperion shares peaked last February, after the FDA approvals, but since then, the stock has declined. The offering gives the company a boost in available capital for further work on its development pipeline and its marketing efforts for bempedoic acid.
Chad Messer, covering ESPR for Needham, sees the note offering as a net positive for Esperion.
We believe this financing should help put to rest concerns regarding Esperion's balance sheet. Despite a challenging launch for NEXLETOL and NEXLIZET, product growth has continued in 3Q against the backdrop of a contracting LDL-C market.
This growth trajectory suggests potential for a rapid acceleration when conditions improve," Messer wrote. See ESPR stock analysis on TipRanks Intercept Pharma ICPT Liver disease is a serious health threat, and Intercept Pharma is focused on developing treatments for some of the more dangerous chronic liver conditions, including nonalcoholic steatohepatitis NASH and primary biliary cholangitis PBC.
Intercept has a research pipeline based on FXR, a regulator of bile acid pathways in the hepatic system. The lead compound, obeticholic acid OCA , is an analog of the bile acid CDCA, and as such can take a role in the FXR pathways and receptors implicated in chronic liver disease.
Treating liver disease through the FXR biology has direct applications for PBC, and is showing promise treating complications from NASH.
The effect on the stock is still felt, and ICPT remains at its week low point. In reaction, in December of , Intercept announced major changes in top-level management, as CEO and President Mark Pruzanski announced he's stepping down effective January 1 of this year.
Pruzanski's dedication to transform the liver space is still strong, and that he will continue to guide ICPT's progress as an advisor and Board member.
Additionally, we have had the pleasure of working closely with Jerry Durso and believe that he will transform the company and lead ICPT's success in growing the PBC market and the path to potential approval and commercial launch of OCA in NASH.
ICPT's Moderate Buy consensus rating is based on 17 reviews, including 8 Buys and 9 Holds. See ICPT stock analysis on TipRanks Gilead Sciences GILD Gilead has had a year like a firework — fast up and fast down.
By November, however, even though remdesivir had been approved, the World Health Organization WHO was recommending against its use, and the COVID vaccines now on the market have made remdesivir irrelevant to the pandemic.
The company has been working, in conjunction with Galapagos GLPG , on development of filgotinib as a treatment for rheumatoid arthritis.Download as PDF Printable version. Retrieved May 29, Zacks Premium - The only way to fully access the Zacks Rank. Wynn Macauthe Denkspiele second project started construction on June 28, Weitere Nachrichten. Suisse FR. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig. Mitglied werden.